Company
Kanvas Biosciences
Building microbial ecosystems for health.
Also known as KANVAS BIOSCIENCES, INC.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- KANVAS BIOSCIENCES, INC.
- kanvasbio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Our full-stack technology platform brings microbiome drug discovery into focus. Our spatial mapping discovery engine provides stunning images of the interactions and connections between host and the microbiome; an area of this vital system that we've never been able to completely understand before. Our integrated in-house manufacturing translates these insights into scalable, reproducible, and clinical-stage therapies designed to precisely modulate host immunity and improve patient outcomes.
Funding snapshot
- Total raised
- $48MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $48M2026-05-06
Funding rounds
- Series A
- $48M2026-05-06, Company stated
- Round, 2024
- $3.9M2024-03-04, SEC form D sold, 54 investors
- Round, 2023
- $11.8M2023-06-01, SEC form D sold, 12 investors
Products
- Web
- KAN-001
- Web
- KAN-004
Loading relationship preview